Sancho-Garnier H - Search Results

1

Phase II study of elliptinium in advanced breast cancer.

Rouësse JG, Le Chevalier T, Caille P, Mondesir JM, Sancho-Garnier H, May-Levin F, Spielmann M, De Jager R, Amiel JL. Rouësse JG, et al. Cancer Treat Rep. 1985 Jun;69(6):707-8. Cancer Treat Rep. 1985. PMID: 4016774

2

[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].

Rouëssé J, Huertas D, Sancho-Garnier H, Le Chevalier T, Amiel JL, Brulé G, Tursz T, Mondésir JM. Rouëssé J, et al. Bull Cancer. 1981;68(5):437-41. Bull Cancer. 1981. PMID: 7037078 Clinical Trial. French.

3

Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.

Le Chevalier T, Arriagada R, Baldeyrou P, Martin M, Duroux P, Jacquotte A, Sancho-Garnier H, Rouesse J. Le Chevalier T, et al. Cancer Treat Rep. 1985 May;69(5):469-72. Cancer Treat Rep. 1985. PMID: 4039979

4

[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].

Rouesse J, Tursz T, Le Chevalier T, Huertas D, Amiel JL, Brule G, Callet B, Droz JP, Voisin PM, Sancho-Garnier H, Le Pecq JB, Paoletti C. Rouesse J, et al. Nouv Presse Med. 1981 May 30;10(24):1997-9. Nouv Presse Med. 1981. PMID: 7255136 French.

5

A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.

Boue F, Pastran Z, Spielmann M, Le Chevalier T, Subirana R, Sevin D, Paoletti C, Brandely M, Avril MF, Sancho-Garnier H, et al. Boue F, et al. Cancer Immunol Immunother. 1990;32(1):67-70. doi: 10.1007/BF01741727. Cancer Immunol Immunother. 1990. PMID: 2126985 Free PMC article. Clinical Trial.

6

Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHIC.

Gouyette A, Ducret JP, Caillé P, Amiel JL, Rouëssé J, Foka M, Carde P, Hayat M, Sancho-Garnier H. Gouyette A, et al. Anticancer Res. 1986 Sep-Oct;6(5):1127-32. Anticancer Res. 1986. PMID: 3800320

7

A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.

Ducret JP, Caillé P, Sancho Garnier H, Amiel JL, Michelson M, Hovanessian AG, Youn JK, Lacour F. Ducret JP, et al. J Biol Response Mod. 1985 Apr;4(2):129-33. J Biol Response Mod. 1985. PMID: 3998763

8

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.

Delarue JC, May-Levin F, Mouriesse H, Contesso G, Sancho-Garnier H. Delarue JC, et al. Br J Cancer. 1981 Dec;44(6):911-6. doi: 10.1038/bjc.1981.291. Br J Cancer. 1981. PMID: 7326200 Free PMC article.

9

Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptors.

Delarue JC, Friedman S, Mouriesse H, May-Levin F, Sancho-Garnier H, Contesso G. Delarue JC, et al. Breast Cancer Res Treat. 1988 May;11(2):173-8. doi: 10.1007/BF01805841. Breast Cancer Res Treat. 1988. PMID: 3401606

10

[Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial].

Benahmed M, Carde P, Laplanche A, Renaux J, Rouesse J, Spielmann M, Sancho-Garnier H. Benahmed M, et al. Bull Cancer. 1985;72(1):30-6. Bull Cancer. 1985. PMID: 2580579 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters